This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Assistance Publique - Hopitaux De Paris (Aphp), Inserm (Institut National De La Santé Et De La Recherche Médicale), Institut Curie. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: The Innovations of Sophie Caillat-Zucman
Introduction
Sophie Caillat-Zucman is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the development of innovative therapies. Her work focuses on enhancing the capabilities of immune cells to target diseases more effectively.
Latest Patents
Sophie holds a patent for "Mucosal-Associated Invariant T (MAIT) Cells Expressing Chimeric Antigen Receptors." This invention represents a breakthrough in the application of chimeric antigen receptors (CARs) in immunotherapy, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Sophie has worked with esteemed institutions such as Institut Curie and Inserm (Institut National de la Santé et de la Recherche Médicale). Her research has been pivotal in understanding and manipulating immune responses, which is crucial for developing new treatments for various diseases.
Collaborations
Sophie has collaborated with notable professionals in her field, including Olivier Lantz. These partnerships have enriched her research and contributed to the advancement of innovative therapeutic strategies.
Conclusion
Sophie Caillat-Zucman is a trailblazer in the field of immunology, with her patent and collaborations reflecting her dedication to innovation. Her work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile